Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16187 | 602 | 43.8 | 87% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
412 | 16030 | GENE DELIVERY//GENE THERAPY//POLYETHYLENIMINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GENE MED GRP | Address | 22 | 68% | 3% | 19 |
2 | GENEMED GRP | Address | 12 | 86% | 1% | 6 |
3 | EXPT TREATMENT CYST FIBROSIS | Address | 7 | 43% | 2% | 13 |
4 | AIRWAY GENE TRANSFER | Author keyword | 6 | 100% | 1% | 4 |
5 | UK CYST FIBROSIS GENE THER Y CONSORTIUM | Address | 4 | 75% | 0% | 3 |
6 | ION TRANSPORT UNIT | Address | 4 | 44% | 1% | 7 |
7 | PROGRAM GENE THER Y | Address | 4 | 23% | 2% | 15 |
8 | IMMUNOPORATION | Author keyword | 3 | 100% | 0% | 3 |
9 | AEROSOL GENE DELIVERY | Author keyword | 3 | 50% | 1% | 4 |
10 | MOL PULMONOL | Address | 3 | 35% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AIRWAY GENE TRANSFER | 6 | 100% | 1% | 4 | Search AIRWAY+GENE+TRANSFER | Search AIRWAY+GENE+TRANSFER |
2 | IMMUNOPORATION | 3 | 100% | 0% | 3 | Search IMMUNOPORATION | Search IMMUNOPORATION |
3 | AEROSOL GENE DELIVERY | 3 | 50% | 1% | 4 | Search AEROSOL+GENE+DELIVERY | Search AEROSOL+GENE+DELIVERY |
4 | AIR WAY EPITHELIAL CELLS | 2 | 67% | 0% | 2 | Search AIR+WAY+EPITHELIAL+CELLS | Search AIR+WAY+EPITHELIAL+CELLS |
5 | CFTR ANTIBODIES | 2 | 67% | 0% | 2 | Search CFTR+ANTIBODIES | Search CFTR+ANTIBODIES |
6 | DEAE DEXTRAN MEDIATED TRANSFECTION | 2 | 67% | 0% | 2 | Search DEAE+DEXTRAN+MEDIATED+TRANSFECTION | Search DEAE+DEXTRAN+MEDIATED+TRANSFECTION |
7 | PULMONARY GENE THERAPY | 2 | 67% | 0% | 2 | Search PULMONARY+GENE+THERAPY | Search PULMONARY+GENE+THERAPY |
8 | AIRWAY EPITHELIA | 1 | 14% | 2% | 10 | Search AIRWAY+EPITHELIA | Search AIRWAY+EPITHELIA |
9 | LUNG GENE THERAPY | 1 | 38% | 0% | 3 | Search LUNG+GENE+THERAPY | Search LUNG+GENE+THERAPY |
10 | PERFLUOROCHEMICAL LIQUID | 1 | 38% | 0% | 3 | Search PERFLUOROCHEMICAL+LIQUID | Search PERFLUOROCHEMICAL+LIQUID |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NASAL EPITHELIUM | 38 | 31% | 17% | 102 |
2 | ION TRANSPORT DEFECT | 12 | 34% | 5% | 28 |
3 | TARGETING TRANSGENE EXPRESSION | 12 | 86% | 1% | 6 |
4 | CPG FREE PLASMIDS | 9 | 83% | 1% | 5 |
5 | PDNA PEI COMPLEXES | 9 | 83% | 1% | 5 |
6 | EPITHELIA IN VIVO | 7 | 67% | 1% | 6 |
7 | TRANSPORT DEFECT | 7 | 32% | 3% | 17 |
8 | MOUSE AIRWAY EPITHELIUM | 6 | 100% | 1% | 4 |
9 | PSEUDOTYPED LENTIVIRUS | 4 | 67% | 1% | 4 |
10 | RAS NULL MICE | 4 | 50% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy | 2009 | 61 | 119 | 45% |
Cystic Fibrosis Gene Therapy in the UK and Elsewhere | 2015 | 1 | 108 | 44% |
Moving forward: cystic fibrosis gene therapy | 2013 | 10 | 56 | 55% |
Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis | 2002 | 86 | 127 | 40% |
Advances in Cell and Gene-based Therapies for Cystic Fibrosis Lung Disease | 2012 | 16 | 119 | 34% |
Gene therapy progress and prospects: cystic fibrosis | 2006 | 55 | 33 | 36% |
Gene therapy in cystic fibrosis | 2013 | 9 | 61 | 39% |
Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy | 2015 | 2 | 99 | 16% |
Progress in Gene and Cell Therapy for Cystic Fibrosis Lung Disease | 2012 | 16 | 167 | 29% |
Gene Therapy Prospects - Intranasal Delivery of Therapeutic Genes | 2012 | 10 | 48 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENE MED GRP | 22 | 68% | 3.2% | 19 |
2 | GENEMED GRP | 12 | 86% | 1.0% | 6 |
3 | EXPT TREATMENT CYST FIBROSIS | 7 | 43% | 2.2% | 13 |
4 | UK CYST FIBROSIS GENE THER Y CONSORTIUM | 4 | 75% | 0.5% | 3 |
5 | ION TRANSPORT UNIT | 4 | 44% | 1.2% | 7 |
6 | PROGRAM GENE THER Y | 4 | 23% | 2.5% | 15 |
7 | MOL PULMONOL | 3 | 35% | 1.0% | 6 |
8 | PROGRAMME LUNG BIOL | 2 | 29% | 1.2% | 7 |
9 | GRP LUNG DEV | 1 | 31% | 0.7% | 4 |
10 | PORTEX P MED GRP | 1 | 50% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000244113 | MOL MED GENE THER Y UNIT//GUTLESS//HELPER DEPENDENT ADENOVIRUS |
2 | 0.0000195339 | CATIONIC LIPID//CATIONIC LIPIDS//CATIONIC LIPOSOME |
3 | 0.0000169917 | CFTR//CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR//GREGORY FLEMING JAMES CYST FIBROSIS |
4 | 0.0000123198 | HYDRODYNAMICS BASED PROCEDURE//HYDRODYNAMICS BASED TRANSFECTION//HYDRODYNAMIC DELIVERY |
5 | 0.0000114974 | RHDNASE//DORNASE ALFA//MUCUS VISCOELASTICITY |
6 | 0.0000112626 | ADENO ASSOCIATED VIRUS//AAV//POWELL GENE THER Y |
7 | 0.0000106072 | HUMAN MOL GENET PROGRAM//BAK FOONG PILL//EPITHELIAL CELL BIOL |
8 | 0.0000095772 | IN UTERO TRANSPLANTATION//FETAL GENE THERAPY//INUTERO TRANSPLANTATION |
9 | 0.0000095076 | MRNA DELIVERY//MRNA TRANSFECTION//RIBOL |
10 | 0.0000092906 | GENE DELIVERY//POLYETHYLENIMINE//POLYPLEX |